Should You Invest in Amphastar (AMPH) Based on Bullish Wall Street Views?Zacks Investment Research • 09/14/23
Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior NotesAccesswire • 09/13/23
Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior NotesAccesswire • 09/11/23
Is Amphastar (AMPH) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 08/11/23
Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 08/11/23
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/09/23
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023Accesswire • 08/08/23
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023Accesswire • 08/02/23
Amphastar Pharmaceuticals (AMPH) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 07/26/23
Amphastar Pharma: A Company Growing Quickly As Acquisitions Likely Fuel GrowthSeeking Alpha • 07/12/23
Amphastar Pharmaceuticals (AMPH) Is Up 0.54% in One Week: What You Should KnowZacks Investment Research • 07/05/23
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?Zacks Investment Research • 06/23/23